SKB BIO-B: DISCLOSEABLE TRANSACTIONSUBSCRIPTION FOR STRUCTURED DEPOSITS
SKB BIO-B: DISCLOSEABLE TRANSACTIONSUBSCRIPTION FOR STRUCTURED DEPOSITS
SKB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
SKB BIO-B: CONNECTED TRANSACTIONPURCHASE OF EQUIPMENT
SKB BIO-B: DISCLOSEABLE TRANSACTIONSUBSCRIPTION FOR WEALTH MANAGEMENT PRODUCTS
SKB BIO-B: INSIDE INFORMATIONPROPOSED IMPLEMENTATION OFTHE H SHARE FULL CIRCULATION BY THE COMPANY
SKB BIO-B: ARTICLES OF ASSOCIATION
SKB BIO-B: List of Directors and their Roles and Functions
SKB BIO-B: (1) POLL RESULTS OF THE 2023 ANNUAL GENERALMEETING HELD ON JUNE 20, 2024(2) APPOINTMENT OF NON-EXECUTIVE DIRECTORAND(3) AMENDMENTS TO THE ARTICLES OF ASSOCIATION
SKB BIO-B: VOLUNTARY ANNOUNCEMENTINVESTIGATIONAL NEW DRUG APPROVAL FOR INNOVATIVE DRUGSKB518 FOR INJECTION BY THE NATIONAL MEDICAL PRODUCTSADMINISTRATION
SKB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
SKB BIO-B: CLOSURE OF REGISTER OF MEMBERS FOR THE 2023 ANNUALGENERAL MEETING TO BE HELD ON JUNE 20, 2024
SKB BIO-B: REVISED FORM OF PROXY FOR THE 2023 ANNUAL GENERAL MEETINGTO BE HELD ON JUNE 20, 2024
SKB BIO-B: SUPPLEMENTAL CIRCULAR(1) PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR(2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATIONAND(3) SUPPLEMENTAL NOTICE OF 2023 ANNUAL GENERAL MEETING
SKB BIO-B: SUPPLEMENTAL NOTICE OF 2023 ANNUAL GENERAL MEETING
SKB BIO-B: List of Directors and their Roles and Functions
SKB BIO-B: (1) RESIGNATION OF EXECUTIVE DIRECTOR(2) RESIGNATION OF SUPERVISORS(3) ELECTION OF THE CHAIRPERSON OF THE SUPERVISORYCOMMITTEE(4) PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTORAND(5) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
SKB BIO-B: VOLUNTARY ANNOUNCEMENTSTUDY RESULTS FOR CORE PRODUCT SACITUZUMAB TIRUMOTECAN(SAC-TMT) AT 2024 ASCO ANNUAL MEETING
SKB BIO-B: FORM OF PROXY FOR THE 2023 ANNUAL GENERAL MEETINGTO BE HELD ON JUNE 20, 2024
SKB BIO-B: NOTICE OF 2023 ANNUAL GENERAL MEETING
No Data